Drug eluting stents: Focus on Cypher™ sirolimus-eluting coronary stents in the treatment of patients with bifurcation lesions

Vascular Health and Risk Management

Volumn 3, Issue 4, 2007, Pages 441-451

  Chieffo, Alaide ^a   Aranzulla, Tiziana Claudia ^a   Colombo, Antonio ^a  

^a SAN RAFFAELE HOSPITAL   (Italy)

Author keywords

Bifurcations; Percutaneous coronary interventions; Sirolimus eluting stent

Indexed keywords

ANTITHROMBOCYTIC AGENT; GLYCOPROTEIN IIB; GLYCOPROTEIN IIIA; PACLITAXEL; RAPAMYCIN;

BALLOON DILATATION; CORONARY ARTERY DISEASE; CORONARY ARTERY OBSTRUCTION; CORONARY SINUS; CORONARY STENT; DRUG BIOAVAILABILITY; DRUG ELUTING STENT; HUMAN; INTERMETHOD COMPARISON; PERCUTANEOUS TRANSLUMINAL ANGIOPLASTY; POSTOPERATIVE COMPLICATION; POSTOPERATIVE THROMBOSIS; RESTENOSIS; REVASCULARIZATION; REVIEW; SURGICAL TECHNIQUE; TRANSLUMINAL CORONARY ANGIOPLASTY;

ALGORITHMS; ANTI-BACTERIAL AGENTS; CORONARY ARTERY DISEASE; CORONARY THROMBOSIS; DRUG-ELUTING STENTS; GRAFT OCCLUSION, VASCULAR; HUMANS; SIROLIMUS;

EID: 35148842980     PISSN: 11766344     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (50)

1. Airoldi F, Stankovic G, Orlic D. 2003. The modified T stenting technique with crushing for bifurcation lesions: immediate results and 6-month clinical outcomes. Am J Cardiol, 92 (Suppl), 64L.
2. Al Suwaidi J, Berger PB, Rihal CS, et al. 2000. Immediate and long-term outcome of intracoronary stent implantation for true bifurcation lesions. J Am Coll Cardiol, 35:929-36.
3. Al Suwaidi J, Yeh W, Cohen HA, et al. 2001. Immediate and one-year outcome in patients with coronary bifurcation lesions in the modern era (NHLBI dynamic registry). Am J Cardiol, 87:1139-44.
4. Aliabadi D, Tilli FV, Bowers TR, et al. 1997. Incidence and angiographic predictors of side branch occlusion following high-pressure intracoronary stenting. Am J Cardiol, 80:994-7.
5. Angiolillo DJ, Fernandez-Ortiz A, Bernardo E, et al. 2005. Identification of low responders to a 300-mg clopidogrel loading dose in patients undergoing coronary stenting. Thromb Res, 115:101-8.
6. Cervinka P, Stasek J, Pleskot M, et al. 2002. Treatment of coronary bifurcation lesions by stent implantation only in parent vessel and angioplasty in sidebranch: immediate and long-term outcome. J Invasive Cardiol, 14:735-40.
7. Chevalier B, Glatt B, Royer T, et al. 1998. Placement of coronary stents in bifurcation lesions by the "culotte" technique. Am J Cardiol, 82:943-9.
8. Colombo A. 2004. Bifurcational lesions and the "crush" technique: understanding why it works and why it doesn't-a kiss is not just a kiss. Catheter Cardiovasc Interv, 63:337-8.
9. Colombo A, Gaglione A, Nakamura S, et al. 1993. "Kissing" stents for bifurcational coronary lesion. Cathet Cardiovasc Diagn, 30:327-30.
10. Colombo A, Iakovou I. 2004a. Drug-eluting stents: the new gold standard for percutaneous coronary revascularisation. Eur Heart J, 25:895-7.
11. Colombo A, Iakovou I. 2004b. Ten years of advancements in interventional cardiology. J Endovasc Ther, 11 Suppl 2, II10-8.
12. Colombo A, Moses JW, Morice MC, et al. 2004. Randomized study to evaluate sirolimus-eluting stents implanted at coronary bifurcation lesions. Circulation, 109:1244-9.
13. Colombo A, Stankovic G, Orlic D, et al. 2003. Modified T-stenting technique with crushing for bifurcation lesions: immediate results and 30-day outcome. Catheter Cardiovasc Interv, 60:145-51.
14. Costa RA, Mintz GS, Carlier SG, et al. 2005. Bifurcation coronary lesions treated with the "crush" technique: an intravascular ultrasound analysis. J Am Coll Cardiol, 46:599-605.
15. Fujii K, Kobayashi Y, Mintz GS, et al. 2003 Dominant contribution of negative remodeling to development of significant coronary bifurcation narrowing. Am J Cardiol, 92:59-61.
16. Ge L, Airoldi F, Iakovou I, et al. 2005a. Clinical and angiographic outcome after implantation of drug-eluting stents in bifurcation lesions with the crush stent technique: importance of final kissing balloon post-dilation. J Am Coll Cardiol, 46:613-20.
17. Ge L, Iakovou I, Cosgrave J, et al. 2006. Treatment of bifurcation lesions with two stents: one year angiographic and clinical follow up of crush versus T stenting. Heart, 92:371-6.
18. Ge L, Tsagalou E, Iakovou I, et al. 2005b. In-hospital and nine-month outcome of treatment of coronary bifurcational lesions with sirolimuseluting stent. Am J Cardiol, 95:757-60.
19. Gobeil F, Lefèvre T, Guyon P, et al. 2002. Stenting of bifurcation lesions using the Bestent: a prospective dual-center study. Catheter Cardiovasc Interv, 55:427-33.
20. Hoye A, Van Mieghem C, Ong A, et al. 2005. Treatment of de novo bifurcation lesions: comparison of Sirolimus- and Paclitaxel-eluting stents. EuroIntervention, 1:24-30.
21. Iakovou I, Ge L, Colombo A. 2005a. Contemporary stent treatment of coronary bifurcations. J Am Coll Cardiol, 46:1446-55.
22. Iakovou I, Schmidt T, Bonizzoni E, et al. 2005b. Incidence, predictors, and outcome of thrombosis after successful implantation of drug-eluting stents. Jama, 293:2126-30.
23. Jim MH, Ho HH, Miu R, et al. 2006. Modified crush technique with double kissing balloon inflation (sleeve technique): a novel technique for coronary bifurcation lesions. Catheter Cardiovasc Interv, 67:403-9.
24. Kastrati A, Mehilli J, Schuhlen H, et al. 2004. A clinical trial of abciximab in elective percutaneous coronary intervention after pretreatment with clopidogrel. N Engl J Med, 350:232-8.
25. Kobayashi Y, Colombo A, Akiyama T, et al. 1998. Modified "T" stenting: a technique for kissing stents in bifurcational coronary lesion. Catheter Cardiovasc Diagn, 43:323-6.
26. Lefèvre T, Louvard Y, Morice MC, et al. 2000. Stenting of bifurcation lesions: classification, treatments, and results. Catheter Cardiovasc Interv, 49:274-83.
27. Lefèvre T, Louvard Y, Morice MC, et al. 2001. Stenting of bifurcation lesions: a rational approach. J Interv Cardiol, 14:573-85.
28. Lemos PA, Serruys PW, Van Domburg RT, et al. 2004. Unrestricted utilization of sirolimus-eluting stents compared with conventional bare stent implantation in the "real world": the Rapamycin-Eluting Stent Evaluated At Rotterdam Cardiology Hospital (RESEARCH) registry. Circulation, 109:190-5.
29. Melikian N, Airoldi F, Di Mario C. 2004. Coronary Bifurcation Stenting: Current techniques outcome and possible future developments. Minerva Cardioangiol, 52:365-78.
30. Moussa IL, Lansky AJ, Lasic Z, et al. 2006. A prospective registry to evaluate sirolimus-eluting stents implanted at coronary bifurcation lesions using the "crush technique. Am J Cardiol, 97:1317-21.
31. Ormiston JA, Currie E, Webster MW, et al. 2004. Drug-eluting stents for coronary bifurcations: insights into the crush technique. Catheter Cardiovasc Interv, 63:332-6.
32. Pan MS, De Lezo JS, Medina A, et al. 2007. Drug-eluting stents for the treatment of bifurcation lesions: a randomized comparison between paclitaxel and sirolimus stents. Am Heart J, 153:15 el-7.
33. Pan M, De Lezo JS, Medina A, et al. 2004. Rapamycin-eluting stents for the treatment of bifurcated coronary lesions: a randomized comparison of a simple versus complex strategy. Am Heart J, 148:857-64.
34. Pan M, Suarez De Lezo J, Medina A, et al. 2002. A stepwise strategy for the stent treatment of bifurcated coronary lesions. Catheter Cardiovasc Interv, 55:50-7.
35. Popma J, Leon M, Topol E. 1994. Atlas of Interventional Cardiology. Philadelphia, PA: Saunders.
36. Safian R. 2001. Bifurcation lesions. Royal Oak, MI: Physician's Press, Safian RD, Freed MS, editors, 222.
37. Sawhney N, Damani S, Price M, et al. 2005. Treatment of Bifurcation Lesions With Sirolimus-Eluting Stents Using the "Crush" and "V" Techniques. Procedural and Clinical outcomes. Presented at the Scientific Sessions of the Trans Catheter Therapeutics, Washington.
38. Schampaert E, Fort S, Adelman AG, et al. 1996. The V-stent: a novel technique for coronary bifurcation stenting. Cathet Cardiovasc Diagn, 39:320-6.
39. Serruys PW, Ong A, Morice MC, et al. 2005. Arterial Revascularisation Therapies Study Part II - Sirolimus-eluting stents for the treatment of patients with multivessel de novo coronary artery lesions. EuroIntervention, 1:147-156.
40. Sharma SK. 2005. Simultaneous kissing drug-eluting stent technique for percutaneous treatment of bifurcation lesions in large-size vessels. Catheter Cardiovasc Interv, 65:10-6.
41. Sheiban I, Albiero R, Marsico F, et al. 2000. Immediate and long-term results of "T" stenting for bifurcation coronary lesions. Am J Cardiol, 85:1141-4, A9.
42. Sianos G, Morel MA, Kappetein AP. 2005. The SYNTAX score: an angiographic tool grading the complexity of coronary artery disease. Eurointervention, 1, 2.
43. Sonoda S, Morino Y, Ako J, et al. 2004. Impact of final stent dimensions on long-term results following sirolimus-eluting stent implantation: serial intravascular ultrasound analysis from the sirius trial. J Am Coll Cardiol, 43:1959-63.
44. Spokojny A, Sanborn T. 1996. The bifurcation lesion. Baltimore, MD: Williams and Wilkins, Ellis SG, Holmes DR Jr., editors. Strategic Approaches in Coronary Intervention, 288.
45. Steigen TK, Maeng M, Wiseth R, et al. 2006. Randomized study on simple versus complex stenting of coronary artery bifurcation lesions: the Nordic bifurcation study. Circulation, 114:1955-61.
46. Takebayashi H, Kobayashi Y, Dangas G, et al. 2003. Restenosis due to underexpansion of sirolimus-eluting stent in a bifurcation lesion. Catheter Cardiovasc Interv, 60:496-9.
47. Tanabe K, Hoye A, Lemos PA, et al. 2004. Restenosis rates following bifurcation stenting with sirolimus-eluting stents for de novo narrowings. Am J Cardiol, 94:115-8.
48. Tsuchida K, Colombo A, Lefèvre T. 2007. The clinical outcome of percutaneous treatment of bifurcation lesions in multivessel coronary artery disease: Insights from the Arterial Revascularization Therapies Study part II (ARTS II). Eur Heart J, 28(4):435-42.
49. Virmani R, Guagliumi G, Farb A, et al. 2004. Localized hypersensitivity and late coronary thrombosis secondary to a sirolimus-eluting stent: should we be cautious? Circulation, 109:701-5.
50. Yamashita T, Nishida T, Adamian MG, et al. 2000. Bifurcation lesions: two stents versus one stent - immediate and follow-up results. J Am Coll Cardiol, 35:1145-51.